Lymphocyte Activity Profile

This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).

Bakesi JG, Grenier K, Roboz J, et al. CD8 lymphocyte subsets provide prognostic measure of HIV disease progression. Int Conf AIDS. 1990; 6:218. Abstract SB 528.

Grenier K, Bach BA, Campbell D, et al. Discordant expression of T-cell activation markers (HLA-DR, CD38, CD25, CD69) as indicators of cellular immune response to HIV infection. Int Conf AIDS. 1990; 6:141. Abstract SA 237.